ARYA Sciences Acquisition Corp V Class A Ordinary Shares
ARYE
ARYE was delisted on the 14th of July, 2023.
54 hedge funds and large institutions have $138M invested in ARYA Sciences Acquisition Corp V Class A Ordinary Shares in 2022 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 6 reducing their positions, and 8 closing their positions.
33% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 6
0% less capital invested
Capital invested by funds: $138M → $138M (-$182K)
0.3% less ownership
Funds ownership: 92.26% → 91.96% (-0.3%)
2% less funds holding
Funds holding: 55 → 54 (-1)
13% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 8
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SC
Sculptor Capital
New York
|
+$4.65M |
| 2 |
CL
CSS LLC
Chicago,
Illinois
|
+$3.95M |
| 3 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$1.99M |
| 4 |
HCM
Highbridge Capital Management
New York
|
+$1.88M |
| 5 |
6CM
683 Capital Management
New York
|
+$968K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HM
HealthCor Management
New York
|
-$4.85M |
| 2 |
CCM
Consonance Capital Management
New York
|
-$2.91M |
| 3 |
CCFM
Cohen & Co Financial Management
New York
|
-$1.94M |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$1.94M |
| 5 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$1.3M |
ARYE Hedge Fund Activity: Q1 2022 in Review
54 of the 6,361 institutional investors tracked by Wall St. Rank reported a position in ARYA Sciences Acquisition Corp V Class A Ordinary Shares (ARYE) for Q1 2022, worth a combined $138M — down 0.13% from $138M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of ARYE and 7 opened new positions — a net loss of 1 holder — while 6 trimmed existing stakes and 8 added.
The largest buyer was Sculptor Capital, adding an estimated $4.65M. The largest seller was HealthCor Management, exiting entirely with an estimated $4.85M sold.
- 54 institutional investors held ARYA Sciences Acquisition Corp V Class A Ordinary Shares (ARYE) as of Q1 2022, down from 55 in Q4 2021.
- Funds reported $138M of ARYA Sciences Acquisition Corp V Class A Ordinary Shares stock for Q1 2022, down 0.13% quarter-over-quarter.
- 7 funds opened new ARYA Sciences Acquisition Corp V Class A Ordinary Shares positions in Q1 2022 and 8 closed out, a net change of -1 holder.
- The largest ARYA Sciences Acquisition Corp V Class A Ordinary Shares buyer in Q1 2022 was Sculptor Capital, an estimated $4.65M added.
- The largest ARYA Sciences Acquisition Corp V Class A Ordinary Shares seller in Q1 2022 was HealthCor Management, an estimated $4.85M sold.
Based on aggregated 13F filings for Q1 2022.